HbA1c: A Review of Analytical and Clinical Aspects
Top Cited Papers
Open Access
- 1 November 2013
- journal article
- review article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 33 (6), 393-400
- https://doi.org/10.3343/alm.2013.33.6.393
Abstract
After the relationship between glycemic control and the HbA1c concentration was demonstrated, many tests have been developed to determine the HbA1c concentration. The test results are standardized to the International Federation of Clinical Chemistry (IFCC) Reference Measurement Procedure (RMP) in harmony with the efforts of the National Glycohemoglobin Standardization Program (NGSP). The longitudinal use of the test requires strict quality management including accreditation of the laboratory, a dedicated internal control design, participation in an external quality assessment (EQA) program (proficiency test), and careful consideration of pre- and post-analytical aspects of the test. Performance goals for optimizing determination of the HbA1c concentration have been described. As an index of long-term glycemic control and a risk predictor, the HbA1c concentration is an indispensable part of routine management of diabetes. Because of the improving quality of the test, the HbA1c concentration is being increasingly applied in the diagnosis of diabetes. There are, however, concerns of this application in point-of-care settings. The HbA1c concentration is also used to achieve stringent control in pregnant diabetic patients. Strict standardization enables the definition of universal reference values and clinical decision limits. This review describes the present status of analytical and clinical aspects of determining the HbA1c concentration and highlights the challenges involved.Keywords
This publication has 32 references indexed in Scilit:
- The long and winding road to optimal HbA1c measurementClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011Diabetic Medicine, 2012
- Standards of Medical Care in Diabetes—2011Diabetes Care, 2011
- Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and AdolescentsDiabetes, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Six of Eight Hemoglobin A1c Point-of-Care Instruments Do Not Meet the General Accepted Analytical Performance CriteriaClinical Chemistry, 2010
- Managing Preexisting Diabetes for PregnancyDiabetes Care, 2008
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- The IFCC Reference Measurement System for HbA1c: A 6-Year Progress ReportClinical Chemistry, 2008
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998